Filters

ANGPTL2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

ANGPTL2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) size: 1.0 µg DNA 322

Supplier ABM LENTIVECTORS
Price 322
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetANGPTL2 Lentiviral Vector (CMV) (pLenti-GIII-CMV)
Short nameANGPTL2 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus), ANGPTL2 Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 490
Gene ANGPTL2
Long gene name angiopoietin like 2
Synonyms gene name angiopoietin-like 2
Synonyms ARP2 HARP
Locus 9q33, 3
Discovery year 2000-02-07
GenBank acession AF125175
Entrez gene record 23452
Pubmed identfication 10473614
RefSeq identity NM_012098
Classification Fibrinogen C domain containing Angiopoietin like
Havana BLAST/BLAT OTTHUMG00000020695

Similar products

Subscribe to our Newsletter